Experts are confident that COVID can cause heart damage. This new study from Washington University School of Medicine and the Veterans Affairs St. Louis Health Care System gives a detailed look at common post-COVID heart issues. The researchers say that the first year after the disease, people who have recovered from COVID will have an increased risk of developing these cardiac problems. Interestingly, they also found that people who had recovered from the disease were less likely to develop these cardiac problems than those who did not.
While heart problems are rare, they can linger, complicating the recovery process. Although these symptoms may be mild, they can still cause a person to have a heart problem. Symptoms of heart failure may include chest pain and shortness of breath, without a lung problem. If these signs persist, they should see a doctor immediately. This is because heart problems can have long-term consequences. A doctor can diagnose a person’s heart problems after COVID-19 infection if these conditions are present.
The study’s results were mixed. The overall average age of participants was 61 years old and comprised 79 percent white individuals. About 17,600 of the participants were female and nearly 37,600 were black. Another 8,000 were of other races, but none were affected by COVID. The Covid-19 cohort had an increased risk of cardiovascular problems a year after the acute phase. These included blood clots, abnormal heart rhythms, and myocardial infarction.
A patient who develops COVID has a higher risk for cardiovascular problems than those without the disease. If the symptoms persist, a doctor will recommend further testing. A doctor can determine if the disease is caused by COVID. In some cases, patients with heart problems can develop POTS. Some of the other common heart problems are chest pain, lightheadedness, and brain fog. This is a rare cause of death in the case of COVID infection.
The Covid-19 cohort averaged 61 years old and included 91 percent white individuals. The study included approximately 37,500 patients with COVID and almost 15,000 of other races. The cohort experienced an increased risk of cardiovascular problems a year after the acute phase. Its most common symptom was inflammation of the heart muscle. The patient had symptoms of anemia, and fatigue. The doctors also noted that the disease affected the other body parts.
While most of the symptoms related to COVID infection are not life-threatening, lingering heart problems can complicate recovery. However, if the symptoms persist after the COVID-19 infection, you should see your doctor immediately. The first step is to consult a cardiologist. Only a doctor can diagnose heart failure and recommend a treatment plan. If you feel a heart problem, you should consult a cardiologist.
Infections with COVID may cause serious health issues such as myocardial infarction and heart muscle inflammation. Other long-term effects of COVID infection include the risk of cardiovascular problems. In addition to heart muscle inflammation, blood clots and myocardial infarction can cause serious complications. In such cases, a coordinated global response is vital. If you have a COVID infection, you need to seek medical treatment as soon as possible.
Those who have heart problems should visit their doctors for a diagnosis. Even if the symptoms are mild, contact a physician for a consultation. Your doctor will be able to advise you on non-emergency heart issues that are not life-threatening. The diagnosis of heart failure after COVID 19 is rare, but if it occurs, your doctor may refer you to a cardiologist for further testing.
Among the findings from the Covid-19 study are heart muscle inflammation and myocardial infarction. The researchers used data from national healthcare databases from the US Department of Veterans Affairs to create a cohort of 153760 participants who survived the first 30 days after infection with COVID-19. They also included a control group of historical and contemporary controls. The results showed that the cohort had an increased risk of cardiovascular problems in the first year after the acute phase of the infection.